Odotech, a Quebec based company, manufactures and commercializes patented electronic noses (e-noses) to measure and monitor odours at waste management plants, composting sites and industrial odor-producing plants. The company faced the challenge of lacking the necessary expertise to efficiently upgrade its product’s performance for different odour sources in various environments.

By diagnosing oral premalignant lesions that might progress to cancer and making better clinical decisions, clinicians can significantly lower the mortality rate, increase quality of life with earlier and less traumatic surgery and reduce healthcare costs.

In partnership with Mitacs-Accelerate intern Julius Adebayo Awe, CancerCare Manitoba has developed an innovative way to determine the progression of prostate cancer in intermediate risk prostate cancer patients through a simple blood test.

For Michael Turcot, vice president of Research and Development at Sonomax, Mitacs Accelerate sped up the prototyping process considerably. “Kuba’s research expertise coupled with the Mitacs funding enabled us to transform the design concept of our product into a refined, working prototype that we can present to potential clients.”